MGMT and central nervous system neoplasm: 2021 WHO classification approves methylome classifiers for a variety of CNS tumor types and subtypes and promoter methylation of O6-Methylguanine-DNA methyltransferase (MGMT) is related to an improved response to temozolomide therapy and a longer OS.